Philipp Reber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Philipp Reber has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Angel V. Peterchev
Duke University
2 shared publications - Christina M. Merrick
Magnetic Tides, Inc
2 shared publications - Cidnee Luu
Department of Mechanical Engineering, The University of British Columbia, Vancouver, BC, Canada
2 shared publications - Daniel Sheltraw
Magnetic Tides Inc., 2397 Shattuck Avenue, Suite 204, Berkeley, CA 94704, USA
2 shared publications - Feiyang Dai
Magnetic Tides Inc., 2397 Shattuck Avenue, Suite 204, Berkeley, CA 94704, USA
2 shared publications - Ian O’KIdhain
UC Berkeley–UCSF Graduate Program in Bioengineering, Berkeley, CA 94720, USA
2 shared publications
Latest Publications
- Open Access
Kilohertz Transcranial Magnetic Perturbation (kTMP) for Upper Extremity Motor Recovery After Stroke: A Nonrandomized Pilot Trial
Structured Importance: Upper extremity impairment is a leading cause of post-stroke disability, yet clinically approved neuromodulation therapies are currently limited by the risks and costs of surgical implantation. There is an unmet need for non-invasive brain stimulation. Objective: To evaluate the feasibility, safety, and preliminary clinical efficacy of a novel form of non-invasive brain stimulation, kilohertz transcranial magnetic perturbation (kTMP), for upper limb motor recovery after stroke. Design: A single-center, open-label trial was conducted between September 2025 and April 2026 and comprised a 4-week standard-of-care baseline period, 4 weeks of active treatment with kTMP combined with motor training, and a 4-week follow-up. Setting: Academic research center. Participants: Seven individuals with chronic stroke and upper extremity motor deficits. Intervention: Four weeks of kTMP (3 sessions/week), a brain stimulation approach using magnetic induction to generate subthreshold electric fields, paired with motor tasks. Main Outcomes: Change in Fugl-Meyer Assessment for Upper Extremity (FMA-UE) scores across study periods (standard-of-care baseline, active treatment, follow up). Secondary outcomes included measures of movement smoothness (Spectral Arc Length, SPARC) and fragmentation (mean velocity peak count), and intervention tolerability ratings. Results: Across 7 participants (mean [SD] age, 57.4 [8.7] years; 4 males; mean [SD] time poststroke, 3.5 [2.1] years). No device-related adverse events occurred, and the intervention was well-tolerated (participants rated sensation intensity at an average of less than 0.5 on a 0-10 scale). FMA-UE scores remained stable during the baseline period (mean change, +0.14 points; 95% CI, –1.21 to 1.50; adjusted P =.98), increased significantly following the kTMP-intervention (mean change, +7.00 points; 95% CI, 5.31 to 8.69; adjusted P =.047), and were sustained at the 4-week follow-up (mean change, –1.33 points; 95% CI, –2.42 to –0.25; adjusted P =.13). Movement smoothness improved significantly within 1 week of kTMP onset (mean change, 1.48 points; 95% CI, 0.49–2.47; adjusted P =.03); movement fragmentation showed a similar but nonsignificant trend. Conclusions and Relevance: This pilot trial provides preliminary evidence that kTMP combined with motor tasks is safe, feasible, and may support upper extremity recovery. These pilot data warrant large, randomized controlled trials to evaluate efficacy in support of poststroke motor recovery. Trial Registration: ClinicalTrials.gov Identifier: NCT06317194 Key Points: Question: Is kilohertz transcranial magnetic perturbation (kTMP) a safe, feasible, and effective non-invasive intervention for improving upper extremity motor recovery in chronic stroke? Findings: In this single-center, open-label pilot trial of 7 participants with chronic stroke, upper extremity motor impairment (FMA-UE) remained stable during a 4-week baseline period and significantly improved (mean change, +7.0 points) following 4 weeks of active kTMP treatment combined with motor tasks, with gains sustained at 4-week follow-up. No device-related adverse events occurred. Meaning: These preliminary findings suggest that kTMP is safe and feasible and may support upper extremity motor recovery after stroke, warranting further evaluation.
Open AccessKilohertz Transcranial Magnetic Perturbation (kTMP) for Upper Extremity Motor Recovery After Stroke: A Nonrandomized Pilot Trial
Structured Importance: Upper extremity impairment is a leading cause of post-stroke disability, yet clinically approved neuromodulation therapies are currently limited by the risks and costs of surgical implantation. There is an unmet need for non-invasive brain stimulation. Objective: To evaluate the feasibility, safety, and preliminary clinical efficacy of a novel form of non-invasive brain stimulation, kilohertz transcranial magnetic perturbation (kTMP), for upper limb motor recovery after stroke. Design: A single-center, open-label trial was conducted between September 2025 and April 2026 and comprised a 4-week standard-of-care baseline period, 4 weeks of active treatment with kTMP combined with motor training, and a 4-week follow-up. Setting: Academic research center. Participants: Seven individuals with chronic stroke and upper extremity motor deficits. Intervention: Four weeks of kTMP (3 sessions/week), a brain stimulation approach using magnetic induction to generate subthreshold electric fields, paired with motor tasks. Main Outcomes: Change in Fugl-Meyer Assessment for Upper Extremity (FMA-UE) scores across study periods (standard-of-care baseline, active treatment, follow up). Secondary outcomes included measures of movement smoothness (Spectral Arc Length, SPARC) and fragmentation (mean velocity peak count), and intervention tolerability ratings. Results: Across 7 participants (mean [SD] age, 57.4 [8.7] years; 4 males; mean [SD] time poststroke, 3.5 [2.1] years). No device-related adverse events occurred, and the intervention was well-tolerated (participants rated sensation intensity at an average of less than 0.5 on a 0-10 scale). FMA-UE scores remained stable during the baseline period (mean change, +0.14 points; 95% CI, –1.21 to 1.50; adjusted P =.98), increased significantly following the kTMP-intervention (mean change, +7.00 points; 95% CI, 5.31 to 8.69; adjusted P =.047), and were sustained at the 4-week follow-up (mean change, –1.33 points; 95% CI, –2.42 to –0.25; adjusted P =.13). Movement smoothness improved significantly within 1 week of kTMP onset (mean change, 1.48 points; 95% CI, 0.49–2.47; adjusted P =.03); movement fragmentation showed a similar but nonsignificant trend. Conclusions and Relevance: This pilot trial provides preliminary evidence that kTMP combined with motor tasks is safe, feasible, and may support upper extremity recovery. These pilot data warrant large, randomized controlled trials to evaluate efficacy in support of poststroke motor recovery. Trial Registration: ClinicalTrials.gov Identifier: NCT06317194 Key Points: Question: Is kilohertz transcranial magnetic perturbation (kTMP) a safe, feasible, and effective non-invasive intervention for improving upper extremity motor recovery in chronic stroke? Findings: In this single-center, open-label pilot trial of 7 participants with chronic stroke, upper extremity motor impairment (FMA-UE) remained stable during a 4-week baseline period and significantly improved (mean change, +7.0 points) following 4 weeks of active kTMP treatment combined with motor tasks, with gains sustained at 4-week follow-up. No device-related adverse events occurred. Meaning: These preliminary findings suggest that kTMP is safe and feasible and may support upper extremity motor recovery after stroke, warranting further evaluation.
- Open Access
- 1 August 2026
- Published by IOP Publishing in Journal of Neural Engineering
- Vol. 23 (4) , 044001
A systematic assessment of safety, tolerability and blinding effectiveness of kilohertz transcranial magnetic perturbation (kTMP)
Objective. Non-invasive brain stimulation (NIBS) techniques are increasingly used to modulate brain activity in basic and translational research. Kilohertz transcranial magnetic perturbation (kTMP) is a recently developed NIBS approach that uses magnetic induction to generate subthreshold electric fields in the brain. kTMP has been shown to modulate cortical excitability while producing no perceptible sensation at the stimulation site. However, its safety and tolerability have not yet been systematically evaluated—a gap this study aims to address. Approach. We conducted sham-controlled experiments, within-subject comparisons, and patient feasibility studies with kTMP, entailing 433 sessions across 143 individuals. Participants rated annoyance, muscle activation, and pain on a 0–10 scale after each session. With primary motor cortex (M1) as the target, we compared active stimulation (∼8 V m −1 cortical field) to sham (0 V m −1 ) in healthy adults and chronic stroke patients. In healthy adults, we compared active vs. sham stimulation applied to dorsolateral prefrontal cortex, superior temporal gyrus, and cerebellum. Additional datasets examined tolerability across active kTMP parameters and multi-session feasibility in stroke patients. Safety monitoring included continuous observation for abnormal motor activity and EMG recording in initial experiments. Main results. No device-related adverse reactions occurred across 433 sessions. EMG monitoring revealed no artifacts, and no participants exhibited involuntary muscle contractions or signs of abnormal cortical excitation. kTMP was well tolerated, with mean ratings for active and sham stimulation remaining below 1.5 (where ‘2’ indicates just-noticeable sensation). Permutation tests showed no significant active–sham differences and bootstrapped 95% confidence intervals consistently fell within the ±1 equivalence margin. When auditory masking was used, participants could not distinguish active from sham stimulation. Significance. kTMP achieves cortical E-fields an order of magnitude higher than conventional subthreshold tES while maintaining robust safety margins and tolerability indistinguishable from sham, supporting its use for rigorous double-blind studies and translational settings. Trial Registration: ClinicalTrials.gov Identifier: NCT06317194.
- 1 August 2026
- Published by IOP Publishing in Journal of Neural Engineering
- Vol. 23 (4) , 044001
Open AccessA systematic assessment of safety, tolerability and blinding effectiveness of kilohertz transcranial magnetic perturbation (kTMP)
Objective. Non-invasive brain stimulation (NIBS) techniques are increasingly used to modulate brain activity in basic and translational research. Kilohertz transcranial magnetic perturbation (kTMP) is a recently developed NIBS approach that uses magnetic induction to generate subthreshold electric fields in the brain. kTMP has been shown to modulate cortical excitability while producing no perceptible sensation at the stimulation site. However, its safety and tolerability have not yet been systematically evaluated—a gap this study aims to address. Approach. We conducted sham-controlled experiments, within-subject comparisons, and patient feasibility studies with kTMP, entailing 433 sessions across 143 individuals. Participants rated annoyance, muscle activation, and pain on a 0–10 scale after each session. With primary motor cortex (M1) as the target, we compared active stimulation (∼8 V m −1 cortical field) to sham (0 V m −1 ) in healthy adults and chronic stroke patients. In healthy adults, we compared active vs. sham stimulation applied to dorsolateral prefrontal cortex, superior temporal gyrus, and cerebellum. Additional datasets examined tolerability across active kTMP parameters and multi-session feasibility in stroke patients. Safety monitoring included continuous observation for abnormal motor activity and EMG recording in initial experiments. Main results. No device-related adverse reactions occurred across 433 sessions. EMG monitoring revealed no artifacts, and no participants exhibited involuntary muscle contractions or signs of abnormal cortical excitation. kTMP was well tolerated, with mean ratings for active and sham stimulation remaining below 1.5 (where ‘2’ indicates just-noticeable sensation). Permutation tests showed no significant active–sham differences and bootstrapped 95% confidence intervals consistently fell within the ±1 equivalence margin. When auditory masking was used, participants could not distinguish active from sham stimulation. Significance. kTMP achieves cortical E-fields an order of magnitude higher than conventional subthreshold tES while maintaining robust safety margins and tolerability indistinguishable from sham, supporting its use for rigorous double-blind studies and translational settings. Trial Registration: ClinicalTrials.gov Identifier: NCT06317194.
- Open Access
Amplitude-modulated kilohertz stimulation targeting beta-band activity disrupts motor learning
Sensorimotor learning is associated with the modulation of neural rhythms in the primary motor cortex (M1). Beta-band activity (“beta”; 15–30 Hz) is suppressed during learning, while delta oscillations (1–4 Hz) become increasingly correlated with movement kinematics as skill improves. These observations have been complemented by experimental manipulations designed to perturb oscillatory activity with externally applied electric fields (E-fields). In non-human primates, invasive beta stimulation has been shown to disrupt motor learning whereas delta stimulation enhanced motor recovery in a stroke model. Causal evidence in humans remains limited, partly because established non-invasive methods cannot achieve continuous, narrowband E-fields at sufficient amplitude in the brain. To address this gap, we employed kilohertz transcranial magnetic perturbation (kTMP), a non-invasive magnetic induction technique that delivers continuous narrowband kilohertz E-fields which can be amplitude-modulated (AM) to target cortical rhythms. We applied AM-kTMP to test the functional relevance of beta and delta activity in human motor learning. In a double-blind mixed design, 40 participants performed a force-control task while receiving AM-kTMP at E-field amplitudes of 8 V/m in M1. We targeted either beta or delta, each paired with a sham condition. AM-kTMP influenced motor performance in a frequency-dependent manner: Beta-kTMP suppressed performance gains relative to both delta-kTMP and sham, whereas delta-kTMP showed no effect. These results suggest that increased beta activity in human M1 can interfere with motor learning. More broadly, kTMP offers a novel approach to probe frequency-specific cortical dynamics.
Open AccessAmplitude-modulated kilohertz stimulation targeting beta-band activity disrupts motor learning
Sensorimotor learning is associated with the modulation of neural rhythms in the primary motor cortex (M1). Beta-band activity (“beta”; 15–30 Hz) is suppressed during learning, while delta oscillations (1–4 Hz) become increasingly correlated with movement kinematics as skill improves. These observations have been complemented by experimental manipulations designed to perturb oscillatory activity with externally applied electric fields (E-fields). In non-human primates, invasive beta stimulation has been shown to disrupt motor learning whereas delta stimulation enhanced motor recovery in a stroke model. Causal evidence in humans remains limited, partly because established non-invasive methods cannot achieve continuous, narrowband E-fields at sufficient amplitude in the brain. To address this gap, we employed kilohertz transcranial magnetic perturbation (kTMP), a non-invasive magnetic induction technique that delivers continuous narrowband kilohertz E-fields which can be amplitude-modulated (AM) to target cortical rhythms. We applied AM-kTMP to test the functional relevance of beta and delta activity in human motor learning. In a double-blind mixed design, 40 participants performed a force-control task while receiving AM-kTMP at E-field amplitudes of 8 V/m in M1. We targeted either beta or delta, each paired with a sham condition. AM-kTMP influenced motor performance in a frequency-dependent manner: Beta-kTMP suppressed performance gains relative to both delta-kTMP and sham, whereas delta-kTMP showed no effect. These results suggest that increased beta activity in human M1 can interfere with motor learning. More broadly, kTMP offers a novel approach to probe frequency-specific cortical dynamics.
- Open Access
- 14 October 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-10
Heartbeat perception is causally linked to frontal delta oscillations
The ability to accurately perceive one’s own bodily signals, such as the heartbeat, plays a vital role in physical and mental health. However, the neurophysiological mechanisms underlying this ability, termed interoception, are not fully understood. Converging evidence suggests that cardiac rhythms are linked to frontal brain activity, particularly oscillations in the delta (0.5 – 4 Hz) band, but their causal relationship remained elusive. Here, we identified a frontal network of delta oscillations that was anticorrelated with both heartbeat perception and heartbeat-evoked brain responses. Using amplitude-modulated transcranial alternating current stimulation (AM-tACS), a method to enhance or suppress brain oscillations in a phase-specific manner, we investigated whether frontal delta oscillations are causally linked to heartbeat perception. We found that enhancement of delta phase synchrony suppressed heartbeat detection accuracy, while suppression of delta phase synchrony enhanced heartbeat detection accuracy. These findings suggest that frontal delta oscillations play a significant role in heartbeat perception, paving the way for causal investigations of interoception and potential clinical applications.
- 14 October 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-10
Open AccessHeartbeat perception is causally linked to frontal delta oscillations
The ability to accurately perceive one’s own bodily signals, such as the heartbeat, plays a vital role in physical and mental health. However, the neurophysiological mechanisms underlying this ability, termed interoception, are not fully understood. Converging evidence suggests that cardiac rhythms are linked to frontal brain activity, particularly oscillations in the delta (0.5 – 4 Hz) band, but their causal relationship remained elusive. Here, we identified a frontal network of delta oscillations that was anticorrelated with both heartbeat perception and heartbeat-evoked brain responses. Using amplitude-modulated transcranial alternating current stimulation (AM-tACS), a method to enhance or suppress brain oscillations in a phase-specific manner, we investigated whether frontal delta oscillations are causally linked to heartbeat perception. We found that enhancement of delta phase synchrony suppressed heartbeat detection accuracy, while suppression of delta phase synchrony enhanced heartbeat detection accuracy. These findings suggest that frontal delta oscillations play a significant role in heartbeat perception, paving the way for causal investigations of interoception and potential clinical applications.